Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 5:238:114464.
doi: 10.1016/j.ejmech.2022.114464. Epub 2022 May 20.

Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress

Zhipei Sang  1 , Keren Wang  2 , Jianghong Dong  3 , Lei Tang  4
Affiliations
Review

Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress

Zhipei Sang et al. Eur J Med Chem. .

Abstract

Alzheimer's disease is a chronic and progressive brain neurodegenerative disease affecting over 30 million people globally. Currently, no effective treatment is available due to multiple factors involved in the progression of AD. Given that the numerous AD-related targets in the disease network, the multi-target-directed ligands (MTDLs) strategy are considered as the promising strategy to treat AD. Herein, the multi-target compounds with/without ChEs are in clinical and in progress are reviewed. To further characterize the drug-likeness, and ADME properties are calculated using the Qikprop. This review will provide highlights for the treatment of AD.

Keywords: ADME property; Alzheimer's disease; Multi-target-directed ligands.

PubMed Disclaimer

LinkOut - more resources